Medfield, MA – Tour24 has announced the appointment of Yinka KuyeRomelus as Chief Operating Officer. About Tour24: Tour24 is a multi-award-winning, on-demand platform and app that provides custom self-guided apartment tours for the multifamily housing…
According to filings with the U.S. Securities and Exchange Commission, Gradiant has raised $400 Million in new Series E funding. The federal securities law requires the notice to be filed by companies that have sold…
Boston, MA – Fiduciary Trust Company has announced the appointment of Frank Brochin as Chief Investment Officer. About Fiduciary Trust Company: Fiduciary Trust Company is a private wealth management firm with a 140-year history of…
According to filings with the U.S. Securities and Exchange Commission, Zapata Quantum is raised $15 Million in new Series Unknown funding. The federal securities law requires the notice to be filed by companies that have…
According to filings with the U.S. Securities and Exchange Commission, AcuityMD is raised $80 Million in new Series C funding. The federal securities law requires the notice to be filed by companies that have sold…
According to filings with the U.S. Securities and Exchange Commission, Orthogon Therapeutics is raised $11 Million in new funding. The federal securities law requires the notice to be filed by companies that have sold securities…
According to filings with the U.S. Securities and Exchange Commission, Alloy Therapeutics is raised $40 Million in new Series E funding. The federal securities law requires the notice to be filed by companies that have…
According to filings with the U.S. Securities and Exchange Commission, Tortugas Neuroscience is raised $106 Million in new Series A funding. The federal securities law requires the notice to be filed by companies that have…
Boston, MA – PanAgora Asset Management Inc. has announced the appointment of Brad Zenz as Director Strategic Relationships. About PanAgora Asset Management Inc.: PanAgora Asset Management Inc. is a quantitative investment manager specializing in distinct…
Powered by the company’s novel Fleuron™ material, Axoft’s iBCI platform enables unprecedented biocompatibility and high quality neural data capture with successful implantation in 11 patients to date. CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axoft, a neurotechnology company, today announced…